AAAAAA

   
Results: 1-20 |
Results: 20
The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
Authors: Casterella, PJ Kereiakes, DJ Steinhubl, SR Raymond, RE Kottke-Marchant, K Patel, K Mueller, M Rosenthal, M Moliterno, DJ Teirstein, PS
Citation: Pj. Casterella et al., The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable, CATHET C IN, 54(4), 2001, pp. 497-504
Statins do not affect platelet inhibition with clopidogrel during coronarystenting
Authors: Serebruany, VL Malinin, AI Callahan, KP Gurbel, PA Steinhubl, SR
Citation: Vl. Serebruany et al., Statins do not affect platelet inhibition with clopidogrel during coronarystenting, ATHEROSCLER, 159(1), 2001, pp. 239-241
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study
Authors: Steinhubl, SR Talley, JD Braden, GA Tcheng, JE Casterella, PJ Moliterno, DJ Navetta, FI Berger, PB Popma, JJ Dangas, G Gallo, R Sane, DC Saucedo, JF Jia, G Lincoff, AM Theroux, P Holmes, DR Teirstein, PS Kereiakes, DJ
Citation: Sr. Steinhubl et al., Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study, CIRCULATION, 103(21), 2001, pp. 2572-2578
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial
Authors: Steinhubl, SR Ellis, SG Wolski, K Lincoff, AM Topol, EJ
Citation: Sr. Steinhubl et al., Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial, CIRCULATION, 103(10), 2001, pp. 1403-1409
Uniform platelet activation exists before coronary stent implantation despite aspirin therapy
Authors: Serebruany, VL Cummings, CC Malinin, AI Steinhubl, SR Gurbel, PA
Citation: Vl. Serebruany et al., Uniform platelet activation exists before coronary stent implantation despite aspirin therapy, AM HEART J, 142(4), 2001, pp. 611-616
Stenting in acute myocardial infarction
Authors: Steinhubl, SR Topol, EJ
Citation: Sr. Steinhubl et Ej. Topol, Stenting in acute myocardial infarction, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 373-390
Aspirin resistance
Authors: Alexander, JH Steinhubl, SR
Citation: Jh. Alexander et Sr. Steinhubl, Aspirin resistance, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 499-514
Aspirin and antiplatelet agents in the prevention of complications of coronary artery disease
Authors: Moore, SA Steinhubl, SR
Citation: Sa. Moore et Sr. Steinhubl, Aspirin and antiplatelet agents in the prevention of complications of coronary artery disease, CONTEMP CAR, 2001, pp. 257-281
Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study
Authors: Steinhubl, SR
Citation: Sr. Steinhubl, Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study, J THROMB TH, 9(3), 2000, pp. 199-205
Clopidogrel and coronary stenting: What is the next question?
Authors: Moore, SA Steinhubl, SR
Citation: Sa. Moore et Sr. Steinhubl, Clopidogrel and coronary stenting: What is the next question?, J THROMB TH, 10(2), 2000, pp. 121-126
Antiplatelet medications and their indications in preventing and treating coronary thrombosis
Authors: Van de Graaff, E Steinhubl, SR
Citation: E. Van De Graaff et Sr. Steinhubl, Antiplatelet medications and their indications in preventing and treating coronary thrombosis, ANN MED, 32(8), 2000, pp. 561-571
Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator
Authors: Steinhubl, SR Moore, SA Lincoff, AM
Citation: Sr. Steinhubl et al., Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator, J THOR SURG, 119(2), 2000, pp. 401-401
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention - Response
Authors: Steinhubl, SR Kottke-Marchant, K Moliterno, DJ Rosenthal, M Topol, EJ Lincoff, AM Coller, BS
Citation: Sr. Steinhubl et al., Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention - Response, CIRCULATION, 102(25), 2000, pp. E186-E186
Antiplatelet agents in cardiology: The choice of therapy
Authors: Steinhubl, SR
Citation: Sr. Steinhubl, Antiplatelet agents in cardiology: The choice of therapy, ANN THORAC, 70(2), 2000, pp. S3-S8
Group recommendations
Authors: Levy, JH Smith, PK LeNarz, LA Lemmer, JH Steinhubl, SR Despotis, GJ Goodnough, LT
Citation: Jh. Levy et al., Group recommendations, ANN THORAC, 70(2), 2000, pp. S43-S43
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting
Authors: Steinhubl, SR Topol, EJ
Citation: Sr. Steinhubl et Ej. Topol, Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting, J THROMB TH, 7(3), 1999, pp. 227-231
Ticlopidine and TTP after coronary stenting - Reply
Authors: Steinhubl, SR Tan, WA Foody, JM Topol, EJ
Citation: Sr. Steinhubl et al., Ticlopidine and TTP after coronary stenting - Reply, J AM MED A, 282(18), 1999, pp. 1718-1719
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting
Authors: Steinhubl, SR Tan, WA Foody, JM Topol, EJ
Citation: Sr. Steinhubl et al., Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting, J AM MED A, 281(9), 1999, pp. 806-810
Rapid platelet-function assay - An automated and quantitative cartridge-based method
Authors: Smith, JW Steinhubl, SR Lincoff, AM Coleman, JC Lee, TT Hillman, RS Coller, BS
Citation: Jw. Smith et al., Rapid platelet-function assay - An automated and quantitative cartridge-based method, CIRCULATION, 99(5), 1999, pp. 620-625
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention
Authors: Steinhubl, SR Kottke-Marchant, K Moliterno, DJ Rosenthal, ML Godfrey, NK Coller, BS Topol, EJ Lincoff, AM
Citation: Sr. Steinhubl et al., Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention, CIRCULATION, 100(19), 1999, pp. 1977-1982
Risultati: 1-20 |